Federal award
ORTHO-CLINICAL DIAGNOSTICS, INC
FA302008F0004
Contract
Obligated and Ceiling
- Obligated (net)
- $662,367.79
- Ceiling (potential value, not spending)
- $1,110,648.33
- Current value
- $886,508.10
- Gross positive obligations
- $1,224,884.54
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ORTHO-CLINICAL DIAGNOSTICS, INC · JG5JF2JQJ121
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- JOHNSON & JOHNSON HEALTHCARE · LKV3QN1ND7D1
- Awarding agency
- Department of War · sub-agency 5700 · office FA3020
- Funding agency
- Department of War · sub-agency 5700
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- FA302008F0004
- Parent vehicle (IDV PIID)
- V797P7126A
- Award type code
- C
- Actions
- 26 · Nov 1, 2007 to Mar 28, 2013
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History26
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Mar 28, 2013 | FY2013 | P00025 | C | −$21,388.66 | — |
| Mar 1, 2013 | FY2013 | P00024 | C | −$36,628.29 | — |
| Dec 5, 2012 | FY2013 | P00023 | D | $0.00 | — |
| Oct 2, 2012 | FY2013 | P00022 | C | $62,000.00 | — |
| Sep 21, 2012 | FY2012 | P00021 | G | $0.00 | — |
| Aug 30, 2012 | FY2012 | P00020 | D | −$69,000.00 | — |
| Oct 13, 2011 | FY2012 | P00019 | C | $224,140.36 | — |
| Sep 22, 2011 | FY2011 | P00018 | G | $0.00 | — |
| Sep 15, 2011 | FY2011 | P00017 | C | −$60,000.00 | — |
| Jun 13, 2011 | FY2011 | P00016 | C | $74,713.47 | — |
| Mar 28, 2011 | FY2011 | P00015 | C | $0.00 | — |
| Jan 21, 2011 | FY2011 | P00014 | C | $82,813.45 | — |
| Oct 13, 2010 | FY2011 | P00013 | C | $74,713.48 | — |
| Sep 19, 2010 | FY2010 | P00012 | C | −$100,000.00 | — |
| Sep 14, 2010 | FY2010 | P00011 | G | $0.00 | — |
| Oct 5, 2009 | FY2010 | P00010 | C | $224,140.36 | — |
| Sep 30, 2009 | FY2009 | P00009 | C | −$51,107.32 | — |
| Sep 10, 2009 | FY2009 | P00008 | G | $0.00 | — |
| Aug 31, 2009 | FY2009 | P00007 | C | $1,722.59 | — |
| Aug 4, 2009 | FY2009 | P00006 | C | $7,462.72 | — |
| Jun 16, 2009 | FY2009 | P00005 | C | −$252.13 | — |
| Nov 24, 2008 | FY2009 | P00004 | M | −$224,140.35 | — |
| Oct 6, 2008 | FY2009 | P00003 | C | $224,140.36 | — |
| Sep 30, 2008 | FY2008 | P00002 | C | $16,038.75 | — |
| Sep 23, 2008 | FY2008 | P00001 | G | $0.00 | — |
| Nov 1, 2007 | FY2008 | 0 | — | $232,999.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.